Iceland· IS-EU/1/21/1550/001
Ponvory
A selective immunosuppressants product containing ponesimodum inn, registered in Iceland by LABORATOIRES JUVISE PHARMACEUTICALS. The same ATC class is registered in 5 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Ponesimodum inn is registered in 5 of 19 countries.
Countries holding a registration under ATC L04AA (selective immunosuppressants), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 2 of them publish a price we can compare per daily dose
Ponesimodum inn · ATC L04AA
5 / 19 countries
- Denmark
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Ponesimodum INN
- Manufacturer
- LABORATOIRES JUVISE PHARMACEUTICALS
- Country
- Iceland (IS)
- ATC code
- L04AA
- ATC class
- Selective immunosuppressants
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ponesimodum inn in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPonvory 10mg tabletsJuvise Pharmaceuticals
- SwitzerlandPonvory 10 mg, FilmtablettenMedius AG
- NorwayPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- CzechiaPONVORYLaboratoires Juvisé Pharmaceuticals, Villeurbanne
- IrelandPonvory 2 mg+3 mg+4 mg+5 mg+6 mg+7 mg+8 mg+9 mg+10 mg film-coated tabletsLaboratoires Juvise Pharmaceuticals
- United StatesPONVORYJanssen Pharmaceuticals, Inc
- SpainPONVORY 2, 3, 4, 5, 6, 7, 8, 9 y 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULALaboratoires Juvise Pharmaceuticals
- FinlandPonvoryLaboratoires Juvise Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Ponvory
- Norway · Ponvory
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7332ebd-96c7-4959-ad28-d73e1eb50b64 GET /v1/drugs/f7332ebd-96c7-4959-ad28-d73e1eb50b64?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "L04AA",
"marketed": false,
"strength": "2 mg+ 3 mg+ 4 mg+ 5 mg+ 6 mg + 7 mg+ 8 mg + 9 mg + 10 mg",
"ma_number": "EU/1/21/1550/001",
"substance": "Ponesimodum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í taugasjúkdómum með sérþekkingu og reynslu í meðferð á MS.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "44335"
}See everything about ponesimodum inn.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.